| |
| |
|
| Insider
Information: |
Schroeder Theodore R |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
22,996 |
|
|
Indirect Shares
|
117,489 |
|
|
| Direct
Value |
$369,493 |
|
|
|
Indirect Value
|
$46,267 |
|
|
| Total
Shares |
140,485 |
|
|
| Total
Value |
$415,760 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -100.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cadence Pharmaceuticals Inc |
CADX |
President, CEO, Director |
2014-03-19 |
0 |
2014-03-19 |
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
Director |
2015-05-07 |
0 |
2014-08-13 |
0 |
Premium* |
|
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2020-05-20 |
11,007 |
2018-05-24 |
0 |
Premium* |
|
|
Nabriva Therapeutics AG |
NBRV |
Director |
2023-01-29 |
11,989 |
2019-08-27 |
117,489 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADX |
Cadence Pharmaceuticals I... |
President, CEO |
• • – |
2009-12-31 |
4 |
AS |
$9.76 |
$191,866 |
I/I |
(19,657) |
471,343 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
President, CEO |
• • – |
2009-10-16 |
4 |
AS |
$10.72 |
$214,376 |
I/I |
(20,000) |
491,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
President, CEOOfficer |
• – – |
2006-10-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
500,000 |
|
- |
|
| CADX |
Cadence Pharmaceuticals I... |
President, CEO |
• • – |
2008-02-20 |
4 |
A |
$5.34 |
$58,740 |
I/I |
11,000 |
511,000 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-11-30 |
4 |
D |
$0.43 |
$517 |
D/D |
(1,211) |
646,396 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
343,800 |
646,560 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-10-31 |
4 |
D |
$0.50 |
$600 |
D/D |
(1,211) |
647,607 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-04-30 |
4 |
D |
$0.55 |
$664 |
D/D |
(1,211) |
648,686 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-09-30 |
4 |
D |
$0.53 |
$645 |
D/D |
(1,211) |
648,818 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-03-31 |
4 |
D |
$0.58 |
$696 |
D/D |
(1,211) |
649,897 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-08-31 |
4 |
D |
$0.62 |
$750 |
D/D |
(1,211) |
650,029 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-02-28 |
4 |
D |
$1.35 |
$1,635 |
D/D |
(1,211) |
651,108 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-07-31 |
4 |
D |
$0.76 |
$920 |
D/D |
(1,211) |
651,240 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-06-30 |
4 |
D |
$0.67 |
$817 |
D/D |
(1,211) |
652,451 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2020-05-31 |
4 |
D |
$1.14 |
$1,381 |
D/D |
(1,211) |
653,662 |
0 |
- |
|
90 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
